Publications by authors named "Gerrit Machetanz"

Claim this Profile
P
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study.
Katharina Linse, Constanze Weber, Peter Reilich, Florian Schöberl, Matthias Boentert, Gerrit Machetanz

Neurol Res Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering genetic mimics in multiple sclerosis: A single-center clinical exome sequencing study.
Julia M Mandler, Johanna Härtl, Isabell Cordts, Marc Sturm, Dennis M Hedderich, Gerrit Machetanz

Mult Scler J Exp Transl Clin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen.
Gerrit Machetanz, Marc Grziwotz, Luisa Semmler, Mathias Maier, Christian Maegerlein

J Neuromuscul Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease therapy: what lies ahead?
Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, Gerrit Machetanz, Antonia F Demleitner

J Neural Transm (Vienna)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis.
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, Gerrit Machetanz, Marcel Naumann

Cells· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.
Milan Zimmermann, Leonie Köhler, Marketa Kovarova, Stefanie Lerche, Claudia Schulte, Gerrit Machetanz

Eur J Neurol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD.
Stefanie Lerche, Claudia Schulte, Isabel Wurster, Gerrit Machetanz, Benjamin Roeben

Mov Disord· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories.
Stefanie Lerche, Isabel Wurster, Benjamin Röben, Milan Zimmermann, Gerrit Machetanz

Mov Disord· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
Stefanie Lerche, Gerrit Machetanz, Isabel Wurster, Benjamin Roeben, Milan Zimmermann

Mov Disord· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease: evolution of cognitive impairment and CSF Aβ profiles in a prospective longitudinal study.
Stefanie Lerche, Isabel Wurster, Benjamin Röben, Gerrit Machetanz, Milan Zimmermann

J Neurol Neurosurg Psychiatry· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD).
Stefanie Lerche, Gerrit Machetanz, Benjamin Roeben, Isabel Wurster, Milan Zimmermann

Neurobiol Aging· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Patricia Sulzer, Sara Becker, Walter Maetzler, Elke Kalbe, Luc van Nueten, Gerrit Machetanz

J Neurol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
Stefanie Lerche, Inga Liepelt-Scarfone, Isabel Wurster, Claudia Schulte, Eva Schäffer, Gerrit Machetanz

Mov Disord· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Therapeutic Potential of Metformin in Neurodegenerative Diseases.
Carola Rotermund, Gerrit Machetanz, Julia C Fitzgerald

Front Endocrinol (Lausanne)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
Eva Reinthaler, Gerrit Machetanz, Christoph Hotzy, Markus Reindl, Franz Fazekas

Mult Scler· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis